These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

33 related articles for article (PubMed ID: 29788025)

  • 1. Does 100% Rapid Review Improve Cervical Cancer Screening?
    Queiroz Filho J; Eleutério J; Ney Cobucci R; de Oliveira Crispim JC; Giraldo PC; Gonçalves AK
    Acta Cytol; 2018; 62(3):209-214. PubMed ID: 29788025
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HPV genotyping for triage of women with abnormal cervical cancer screening results: a multicenter prospective study.
    Nakamura Y; Matsumoto K; Satoh T; Nishide K; Nozue A; Shimabukuro K; Endo S; Nagai K; Oki A; Ochi H; Morishita Y; Noguchi M; Yoshikawa H
    Int J Clin Oncol; 2015 Oct; 20(5):974-81. PubMed ID: 25652908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Punch biopsy guided by both colposcopy and HR-HPV status is more efficient for identification of immediate high-grade squamous intraepithelial lesion or worse among HPV-infected women with atypical squamous cells of undetermined significance.
    Ding Z; Li Y; Chen A; Song M; Zhang Y
    Eur J Obstet Gynecol Reprod Biol; 2016 Dec; 207():32-36. PubMed ID: 27816739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Utility of P16 expression and Ki-67 proliferation index in ASCUS and ASC-H pap tests.
    Toll AD; Kelly D; Maleki Z
    Diagn Cytopathol; 2014 Jul; 42(7):576-81. PubMed ID: 24288264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of Implementing 100% Rapid Review as a Quality Control Tool in Cervical Cytology.
    Magalhães JC; Ázara CZS; Tavares SBDN; Manrique EJC; Amaral RG
    Acta Cytol; 2018; 62(2):115-120. PubMed ID: 29597202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the LC-1000 Flow Cytometry Screening System for Cervical Cancer Screening in Routine Health Checkups.
    Heo I; Kwak HJ; Nah EH; Cho S; Kim S; Cho HI
    Acta Cytol; 2018; 62(4):279-287. PubMed ID: 29843120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Follow-up of women with cervical cytological abnormalities showing atypical squamous cells of undetermined significance or low-grade squamous intraepithelial lesion: a nationwide cohort study.
    Sundström K; Lu D; Elfström KM; Wang J; Andrae B; Dillner J; Sparén P
    Am J Obstet Gynecol; 2017 Jan; 216(1):48.e1-48.e15. PubMed ID: 27457115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atypical Squamous Cells in Liquid-Based Cervical Cytology: Microbiology, Inflammatory Infiltrate, and Human Papillomavirus-DNA Testing.
    Gomes de Oliveira G; Eleutério RMN; Silveira Gonçalves AK; Giraldo PC; Eleutério J
    Acta Cytol; 2018; 62(1):28-33. PubMed ID: 29130974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risks of CIN 2+, CIN 3+, and Cancer by Cytology and Human Papillomavirus Status: The Foundation of Risk-Based Cervical Screening Guidelines.
    Demarco M; Lorey TS; Fetterman B; Cheung LC; Guido RS; Wentzensen N; Kinney WK; Poitras NE; Befano B; Castle PE; Schiffman M
    J Low Genit Tract Dis; 2017 Oct; 21(4):261-267. PubMed ID: 28953116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HPV mRNA is more specific than HPV DNA in triage of women with minor cervical lesions.
    Sørbye SW; Fismen S; Gutteberg TJ; Mortensen ES; Skjeldestad FE
    PLoS One; 2014; 9(11):e112934. PubMed ID: 25405981
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of atypical squamous cells of undetermined significance or low-grade squamous intraepithelial lesions of the uterine cervix with human papilloma virus infection among young women aged less than 25 years.
    Ryu KJ; Lee S; Min KJ; Hong JH; Song JY; Lee JK; Lee NW
    Diagn Cytopathol; 2016 Dec; 44(12):959-963. PubMed ID: 27714942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Daily peer review of abnormal cervical smears in the assessment of individual practice as an additional method of internal quality control.
    Confortini M; Di Stefano C; Biggeri A; Bulgaresi P; Di Claudio G; Grisotto L; Maddau C; Matucci M; Petreschi C; Troni GM; Turco P; Foxi P
    Cytopathology; 2016 Feb; 27(1):35-42. PubMed ID: 25123613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of 100% Rapid Review as an Effective Tool for Internal Quality Control in Cytopathological Services.
    Queiroz Filho J; de Oliveira Crispim Freitas JC; Caldas Pessoa D; Eleutério Júnior J; Giraldo PC; Gonçalves AK
    Acta Cytol; 2017; 61(3):207-213. PubMed ID: 28521328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevaccination distribution of human papillomavirus types in women attending at cervical cancer screening in Belgium.
    Arbyn M; Benoy I; Simoens C; Bogers J; Beutels P; Depuydt C
    Cancer Epidemiol Biomarkers Prev; 2009 Jan; 18(1):321-30. PubMed ID: 19124515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the performance of the NucliSENS EasyQ HPV E6/E7 mRNA assay and HPV DNA chip for testing squamous cell lesions of the uterine cervix.
    Munkhdelger J; Choi Y; Lee D; Kim S; Kim G; Park S; Choi E; Jin H; Jeon BY; Lee H; Park KH
    Diagn Microbiol Infect Dis; 2014 Aug; 79(4):422-7. PubMed ID: 24856365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic accuracy of high-risk HPV genotyping in women with high-grade cervical lesions: evidence for improving the cervical cancer screening strategy in China.
    Xu H; Lin A; Shao X; Shi W; Zhang Y; Yan W
    Oncotarget; 2016 Dec; 7(50):83775-83783. PubMed ID: 27626178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reproducibility of cervical cytopathology following an intervention by an external quality control laboratory.
    Ázara CZ; Manrique EJ; Tavares SB; Alves de Souza NL; Magalhães JC; Amaral RG
    Diagn Cytopathol; 2016 Apr; 44(4):305-10. PubMed ID: 26848707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cervical Cancer Screening Beliefs and Prevalence of LSIL/HSIL Among a University-Based Population in Cameroon.
    Eakin C; Ekollo R; Nembulefack D; Halle-Ekane G; Tangui G; Brady R; Bhattarai B; Orock GE; Greenspan D
    J Low Genit Tract Dis; 2018 Oct; 22(4):274-279. PubMed ID: 30256335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Performance of Laboratories after 10 Years of Participating in External Quality Monitoring in Cervical Cytology.
    de Morais LSF; Magalhães JC; Braga IDS; Marega LA; Tavares SBDN; Amaral RG
    Acta Cytol; 2020; 64(3):224-231. PubMed ID: 31480038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endocervical Cytology: Inter- and Intra-Observer Variability in Conventional Pap Smears.
    Pulkkinen J; Huhtala H; Krogerus LA; Hollmén S; Laurila M; Kholová I
    Acta Cytol; 2022; 66(3):206-215. PubMed ID: 35226896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 2.